The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has cautioned Maiden Pharmaceuticals of suspension of its certificate th...

"Alleged supply of substandard paediatric medicines by your company led to the death of 66 children and has brought bad reputation to the I...

These include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...

Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory-confirmed COVID-19 in adults and ...

“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...

In late May, BDR had sought the approval of India’s drug regulator to make and sell remdesivir in India without entering into an arrangemen...

ET had reported on May 5 that Gilead Sciences was in talks with several Indian companies including Jubilant Life Sciences for a licensing d...

A senior World Trade Organisation official has cautioned against countries pursuing policies of import substitution, which will be harmful ...

There are many companies dealing in manufacturing and export of generic pharmaceutical drugs under contract manufacturing arrangement.

Hospitals in Maharashtra, both government and semi-government, have sufficient stock of swine flu drugs which are available for free, said ...

CCI has rejected a complaint against Gilead Sciences Inc that alleged the US-based pharmaceutical company of abusing its dominant position.

Drug maker Lupin said it has settled patent suit with Medicis Pharmaceutical and signed a pact for development of multiple therapeutic comp...

Ranbaxy Laboratories, Matrix Laboratories, Hetero Drugs and Strides Arcolab can make and sell the three drugs in 100 countries by paying ro...

Mid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina.

MNCs going in for mergers and acquisitions will soon be required to divest some of their patented technologies to a third-party rival .

Ranbaxy Laboratories Ltd said on Monday that it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing ...